Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Williams de Broe was a prominent UK-based wealth management and stockbroking firm with a history dating back to 1869. The firm was well-regarded in the financial community for its specialized equity research, particularly in the healthcare, biotechnology, and pharmaceutical sectors, where its analysts provided deep coverage of emerging life science companies. After being owned by ING Group and the Evolution Group, the company was acquired by Investec in 2012 for approximately £233 million (as part of the Evolution Group deal). Following the acquisition, the Williams de Broe brand was retired and its operations were integrated into Investec Wealth & Investment. During its tenure, the firm served as a significant advisor and broker for numerous mid-cap companies in the UK life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Williams de Broe.